📰 Sheet Data News
Page 6 - Sheet Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sheet Data. Real-time updates on events, politics, business and more.
September 8, 2023
INDIANAPOLIS, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended ...
September 6, 2023
For its first quarter ended July 23, 2023, Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) announces net earnings of $834.1 million, representing $0.85 per share on a diluted basis, compared with $872.4 million for the corresponding quarter of fiscal 2023, representing $0.85 per share on a diluted basis. The results for the first quarter of fiscal 2024 were affected by pre-tax acquisition costs of $3.5 million, as well as by a pre-tax net foreign...
September 6, 2023
Net earnings were $834.1 million, or $0.85 per diluted share for the first quarter of fiscal 2024 compared with $872.4 million, or $0.85 per diluted share for...
September 6, 2023
For its first quarter ended July 23, 2023, Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) announces net earnings of $834.1 million, representing $0.85 per share on a diluted basis, compared with $872.4 million for the corresponding quarter of fiscal 2023, representing $0.85 per share on a diluted basis. The results for the first quarter of fiscal 2024 were affected by pre-tax acquisition costs of $3.5 million, as well as by a pre-tax net foreign...
August 25, 2023
Investegate announcements from MD&A for the three and 12 months ended Feb 28 2023
August 14, 2023
Continued June 30, 2023 December 31, 2022 Balance Sheet Data: Cash and cash equivalents $ 199,845 $ 213,975 Current... -Today at 02:19 pm- MarketScreener
August 10, 2023
-- Total revenue of $8.7M in 2QFY23 - increased by 53% year over yearSAN DIEGO, Aug. 10, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology solutions, today reported... -Today at 04:07 pm- MarketScreener
August 10, 2023
/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...
August 8, 2023
Diversification and operational focus leads to sequential margin expansion Second Quarter 2023 Highlights Net sales of $1.0 billion in the second quarter, down 34% year-over-year Net income...
August 2, 2023
Strong Second Quarter Earnings – Continued Dividend ...